Mercury Laboratories Plant Head Sandip Patel Resigns for Career Advancement

1 min read     Updated on 29 Apr 2026, 12:14 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Mercury Laboratories Limited announced the resignation of Mr. Sandip Patel, Plant Head-Jarod and Senior Management Personnel, effective April 28, 2026. The departure was attributed to better career opportunities and advancement, with no other material reasons cited. The company has complied with all regulatory disclosure requirements under SEBI regulations.

powered bylight_fuzz_icon
38990657

*this image is generated using AI for illustrative purposes only.

Mercury laboratories has announced the resignation of Mr. Sandip Patel, Plant Head-Jarod, from his position as Senior Management Personnel (SMP). The resignation became effective from the closure of business hours on April 28, 2026, as communicated to the BSE on April 29, 2026.

Resignation Details

The company has provided comprehensive details about the senior management change in compliance with regulatory requirements:

Parameter: Details
Name and Designation: Mr. Sandip Patel, Plant Head-Jarod
Effective Date: April 28, 2026 (Closure of business hours)
Reason: Better opportunities and career advancement
Status: Senior Management Personnel (SMP)

Regulatory Compliance

Mercury Laboratories has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was submitted to the Corporate Relations Department of BSE Limited, providing all necessary documentation including the resignation letter and detailed annexures.

The company confirmed that there are no other material reasons for the resignation beyond those stated in the formal resignation letter. Mr. Patel expressed gratitude for the opportunities, guidance, and support received during his tenure with the organization.

Management Transition

In his resignation letter dated April 28, 2026, Mr. Patel acknowledged the privilege of being part of Mercury Laboratories Limited and thanked the board members and colleagues for their guidance, support, and cooperation throughout his tenure. The resignation was formally accepted by the management on the same date.

The company has ensured proper documentation and regulatory compliance for this senior management transition, maintaining transparency with stakeholders and regulatory authorities.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.45%-3.16%+0.17%-16.42%-10.33%-11.74%

Who will Mercury Laboratories appoint as the new Plant Head for their Jarod facility and what timeline are they targeting for this replacement?

Could this senior management departure signal potential operational challenges or strategic shifts at Mercury Laboratories' Jarod plant?

How might the leadership transition at the Jarod facility impact Mercury Laboratories' production capacity and ongoing pharmaceutical projects?

Mercury Laboratories Submits Q4FY26 SEBI Compliance Certificate for Dematerialisation Process

1 min read     Updated on 06 Apr 2026, 10:34 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mercury Laboratories Limited filed its Q4FY26 certificate under SEBI Regulation 74(5) on April 6, 2026, confirming compliance with dematerialisation procedures. The certificate from registrar MUFG Intime India validates proper handling of securities received from depository participants during the quarter ended March 31, 2026, and adherence to prescribed timelines for processing and member register updates.

powered bylight_fuzz_icon
37040649

*this image is generated using AI for illustrative purposes only.

Mercury Laboratories Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, demonstrating adherence to regulatory requirements for securities dematerialisation processes.

Regulatory Compliance Filing

The pharmaceutical company filed the mandatory certificate on April 6, 2026, with BSE Limited through Company Secretary Krishna Shah. The submission fulfills requirements under Regulation 74(5) of Securities Exchange Board of India (Depositories and Participants) Regulations, 2018.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 6, 2026
Regulation: SEBI 74(5)
Scrip Code: 538964

Registrar Confirmation

MUFG Intime India Private Limited, serving as Mercury Laboratories' Registrar and Share Transfer Agent, issued the compliance certificate on April 3, 2026. The registrar confirmed proper handling of securities received from depository participants during the quarter.

Sr. Vice President Ashok Shetty signed the certificate on behalf of MUFG Intime India, confirming that:

  • Securities received for dematerialisation were properly confirmed to depositories
  • All securities have been listed on relevant stock exchanges
  • Security certificates were mutilated and cancelled after verification
  • Depository names were substituted in member registers within prescribed timelines

Process Verification

The certificate validates that Mercury Laboratories maintained compliance with SEBI's dematerialisation regulations throughout Q4FY26. The registrar confirmed that all securities comprised in certificates received during the quarter have been listed on stock exchanges where the company's previously issued securities are traded.

Corporate Information

Mercury Laboratories operates from multiple locations including its head office and Factory-1 at Gorwa Industrial Estate, Vadodara, and Factory-2 at Halol-Vadodara Road. The company's registered office is located at Shreeji Bhuvan, Mumbai. MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the company's registrar from its Mumbai office.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.45%-3.16%+0.17%-16.42%-10.33%-11.74%

How might Mercury Laboratories' consistent regulatory compliance impact investor confidence and institutional investment interest in the coming quarters?

What strategic initiatives could Mercury Laboratories pursue to leverage its strong compliance track record for potential market expansion or partnerships?

Will the pharmaceutical sector see increased scrutiny on dematerialisation compliance, and how might this affect smaller players compared to established companies like Mercury Laboratories?

More News on Mercury Laboratories

1 Year Returns:-10.33%